Screening of human gene promoter activities using transfected-cell arrays.
暂无分享,去创建一个
S. Haas | H. Lehrach | P. Rosenstiel | M. Yaspo | M. Janitz | W. Nietfeld | T. Manke | Robert Querfurth | Xi Cheng | A. Guerasimova | Hans-Jörg Warnatz | D. Vanhecke
[1] A. Godzik,et al. A Novel PAAD-containing Protein That Modulates NF-κB Induction by Cytokines Tumor Necrosis Factor-α and Interleukin-1β* , 2002, The Journal of Biological Chemistry.
[2] M. Janitz,et al. High-throughput gene silencing using cell arrays , 2004, Oncogene.
[3] H. Lehrach,et al. Cell array-based intracellular localization screening reveals novel functional features of human chromosome 21 proteins , 2006, BMC Genomics.
[4] D. Sabatini,et al. Microarrays of cells expressing defined cDNAs , 2001, Nature.
[5] A. Godzik,et al. A novel PAAD-containing protein that modulates NF-kappa B induction by cytokines tumor necrosis factor-alpha and interleukin-1beta. , 2002, The Journal of biological chemistry.
[6] J. Fernández-Luna,et al. NLRP2, an Inhibitor of the NF-κB Pathway, Is Transcriptionally Activated by NF-κB and Exhibits a Nonfunctional Allelic Variant1 , 2007, The Journal of Immunology.
[7] H. Lehrach,et al. An efficient and economic enhancer mix for PCR. , 2006, Biochemical and biophysical research communications.
[8] J. Kere,et al. Expression Analysis of the NLRP Gene Family Suggests a Role in Human Preimplantation Development , 2008, PloS one.
[9] S. Akira,et al. Cutting Edge: Role of Toll-Like Receptor 1 in Mediating Immune Response to Microbial Lipoproteins1 , 2002, The Journal of Immunology.
[10] Martin Vingron,et al. T-STAG: resource and web-interface for tissue-specific transcripts and genes , 2005, Nucleic Acids Res..
[11] Thomas Lengauer,et al. CpG Island Mapping by Epigenome Prediction , 2007, PLoS Comput. Biol..
[12] R. Myers,et al. Comprehensive analysis of transcriptional promoter structure and function in 1% of the human genome. , 2005, Genome research.
[13] T. Wang,et al. Use of murine embryonic fibroblasts to define Toll-like receptor activation and specificity , 2004, Journal of endotoxin research.
[14] Martin Vingron,et al. Genome-scale design of PCR primers and long oligomers for DNA microarrays. , 2003, Nucleic acids research.
[15] E. Fikrig,et al. Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in TLR1- and TLR2-deficient mice , 2002, Nature Medicine.
[16] Yong Wang,et al. An evaluation of new criteria for CpG islands in the human genome as gene markers , 2004, Bioinform..
[17] M. Bucan,et al. Promoter features related to tissue specificity as measured by Shannon entropy , 2005, Genome Biology.
[18] Yoann Roupioz,et al. Quantitative analysis of highly parallel transfection in cell microarrays. , 2004, Nucleic acids research.
[19] T. Oelgeschläger,et al. Core promoter-selective RNA polymerase II transcription. , 2006, Biochemical Society symposium.
[20] Alexander E. Kel,et al. MATCHTM: a tool for searching transcription factor binding sites in DNA sequences , 2003, Nucleic Acids Res..
[21] William Stafford Noble,et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project , 2007, Nature.
[22] Ferenc Müller,et al. New Problems in RNA Polymerase II Transcription Initiation: Matching the Diversity of Core Promoters with a Variety of Promoter Recognition Factors* , 2007, Journal of Biological Chemistry.
[23] H. Lehrach,et al. High-throughput mammalian two-hybrid screening for protein-protein interactions using transfected cell arrays , 2008, BMC Genomics.
[24] J. T. Kadonaga,et al. The RNA polymerase II core promoter - the gateway to transcription. , 2008, Current opinion in cell biology.
[25] J. Fernández-Luna,et al. NLRP2, an inhibitor of the NF-kappaB pathway, is transcriptionally activated by NF-kappaB and exhibits a nonfunctional allelic variant. , 2007, Journal of immunology.
[26] Daiya Takai,et al. Comprehensive analysis of CpG islands in human chromosomes 21 and 22 , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[27] Marcel H. Schulz,et al. A Global View of Gene Activity and Alternative Splicing by Deep Sequencing of the Human Transcriptome , 2008, Science.
[28] Paul B. Fisher,et al. mda-5: An interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[29] José Martínez-Aroza,et al. CpGcluster: a distance-based algorithm for CpG-island detection , 2006, BMC Bioinformatics.
[30] E. Wingender,et al. MATCH: A tool for searching transcription factor binding sites in DNA sequences. , 2003, Nucleic acids research.
[31] M. Frommer,et al. CpG islands in vertebrate genomes. , 1987, Journal of molecular biology.
[32] S. Schreiber,et al. Expression signatures, barriers and beyond: the role of oxidative stress in murine colitis and human inflammatory bowel disease revisited , 2008, European journal of gastroenterology & hepatology.
[33] P. Bucher. Weight matrix descriptions of four eukaryotic RNA polymerase II promoter elements derived from 502 unrelated promoter sequences. , 1990, Journal of molecular biology.
[34] M. Janitz,et al. Functional genomics using high-throughput RNA interference. , 2005, Drug discovery today.
[35] Boris Lenhard,et al. Mammalian RNA polymerase II core promoters: insights from genome-wide studies , 2007, Nature Reviews Genetics.
[36] M. Brčić,et al. The response of HEK293 cells transfected with bovine TLR2 to established pathogen-associated molecular patterns and to bacteria causing mastitis in cattle. , 2008, Veterinary immunology and immunopathology.
[37] F. Re,et al. Importance of extra- and intracellular domains of TLR1 and TLR2 in NFκB signaling , 2003, The Journal of cell biology.
[38] S. Pestka,et al. Expression analysis and genomic characterization of human melanoma differentiation associated gene-5, mda-5: a novel type I interferon-responsive apoptosis-inducing gene , 2004, Oncogene.
[39] J. Herman,et al. Gene silencing in cancer in association with promoter hypermethylation. , 2003, The New England journal of medicine.